Asensus Surgical Inc. (AMEX:ASXC) trading with an addition of $0.06 to $1.86 on Thursday, an upside of 3.33 percent. An average of 1,584,073 shares of common stock have been traded in the last five days. There was a gain of $0.1105 in the past week, and it reached a new high 16 times over the past 12 months. The last 20 days have seen an average of 3,371,128 shares traded, while the 50-day average volume stands at 3,690,885.
ASXC stock has decreased by -7.22% in the last month. The company shares reached their 1-month lowest point of $1.6800 on 10/11/21. With the stock rallying to its 52-week high on 02/10/21, shares of the company touched a low of $0.35 and a high of $6.95 in 52 weeks. It has reached a new high 8 times so far this year and achieved 188.00% or $1.2655 in price. In spite of this, the price is down -73.24% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
127 days have passed since Asensus Surgical Inc. (ASXC) last reported insider trading activity. Fernando Anthony C. J., who is President and CEO, most recently acquired $295,682 shares at $3.10 per share on Jun 09. In this transaction, the insider spent $916,613. President and CEO, Fernando Anthony C. J., disposed of 2,112 shares at a price of $3.51 on Jun 08. The insider now owns more than $7,413 worth of shares.
Asensus Surgical Inc. (ASXC) has a trailing price-to-earnings (P/E) ratio of 26.30 for the broader industry and 32.77 for the sector. The stock’s beta is 1.57. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 85.09, the price-to-book (PB) ratio at 2.14.
The quick ratio of Asensus Surgical Inc. for the three months ended June 29 was 19.40, and the current ratio was 20.90, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. On the profitability front, the trailing 12-month gross margin is -46.40% against a 5-year average of -27.6%. Asensus Surgical Inc.’s EBITDA margin for the year ending June 29 is -1351.65%. Its gross profit as reported stood at -$1.99 million compared to revenue of $3.17 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Asensus Surgical Inc.’s return on assets was -40.00%, compared to -65.3% over the last five years. In the past year, the return on investment has been -91.40%, and the 5-year average is -84.3%. Meanwhile, the return on equity (ROE) for the past 12 months has been -45.20% and the 5-year average holds at -90.9%. For the broader industry, ROE averaged 3.96 over the past year.
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$13.17 million in the quarter, while revenues of -$17.34 million were shrunk -7.37%. The analyst consensus anticipated Asensus Surgical Inc.’s latest quarter earnings to come in at -$0.06 per share, but it turned out to be -$0.06, a 0.00% surprise. For the quarter, EBITDA amounted to -$12.44 million. Shareholders own equity worth $234.32 million.
From a technical analysis perspective, let’s take a brief look at Asensus Surgical Inc. (ASXC) price momentum. RSI 9-day as of the close on 13 October was 56.20%, suggesting the stock is Neutral, with historical volatility in this time frame at 53.90%.
As of today, ASXC’s price is $1.7961 +6.21% or $0.1105 from its 5-day moving average. ASXC is currently trading -3.05% lower than its 20-day SMA and -6.87% lower than its 100-day SMA. However, the stock’s current price level is -18.16% below the SMA50 and +230.85% above the SMA200.
The stochastic %K and %D were 54.81% and 36.75%, respectively, and the average true range (ATR) was 0.1033. With the 14-day stochastic at 80.96% and the average true range at 0.1139, the RSI (14) stands at 50.08%. The stock has reached 0.0679 on the 9-day MACD Oscillator while the 14-day reading was at 0.0466.
H.C. Wainwright launched coverage on Asensus Surgical Inc. (AMEX: ASXC) in its analyst report released on May 26, 2021. The firm assigned the stock a a Buy rating.The consensus rating for Asensus Surgical Inc. (ASXC) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ASXC, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is ASXC’s price target for the next 12 months?
Analysts predict a range of price targets between $4.00 and $4.00, with a median target of $4.00. Taking a look at these predictions, the average price target given by analysts for Asensus Surgical Inc. (ASXC) stock is $4.00.